Arvee Laboratories (India) Limited (ARVEE) — Cash Flow-to-Debt Ratio
Arvee Laboratories (India) Limited (ARVEE) has a Cash Flow-to-Debt Ratio of 0.15x as of September 2025, meaning its operating cash flow of Rs13.56 Million could theoretically repay 0% of its total liabilities (Rs91.40 Million) in one year. See Arvee Laboratories (India) Limited leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Arvee Laboratories (India) Limited Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Arvee Laboratories (India) Limited across 13 annual periods. For the full cash flow conversion analysis, see Arvee Laboratories (India) Limited (ARVEE) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Arvee Laboratories (India) Limited (2013–2025)
Year-by-year debt coverage analysis for Arvee Laboratories (India) Limited. Check Arvee Laboratories (India) Limited cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | Rs1.19 Million | Rs68.97 Million | ▼ -95.7% |
| 2024 | 0.40x | Rs36.64 Million | Rs90.85 Million | ▲ +46.3% |
| 2023 | 0.28x | Rs29.29 Million | Rs106.23 Million | ▲ +496.6% |
| 2022 | 0.05x | Rs6.81 Million | Rs147.43 Million | ▼ -47.0% |
| 2021 | 0.09x | Rs17.11 Million | Rs196.08 Million | ▼ -87.4% |
| 2020 | 0.69x | Rs103.34 Million | Rs149.36 Million | ▲ +51.4% |
| 2019 | 0.46x | Rs94.56 Million | Rs206.88 Million | ▲ +127.3% |
| 2018 | 0.20x | Rs60.16 Million | Rs299.18 Million | ▲ +96.8% |
| 2017 | 0.10x | Rs32.17 Million | Rs314.81 Million | ▼ -46.6% |
| 2016 | 0.19x | Rs62.26 Million | Rs325.69 Million | ▼ -45.2% |
| 2015 | 0.35x | Rs85.94 Million | Rs246.14 Million | ▲ +1745.5% |
| 2014 | -0.02x | Rs-3.05 Million | Rs143.60 Million | ▼ -104.9% |
| 2013 | 0.44x | Rs38.55 Million | Rs88.14 Million | — |